40 research outputs found
Applications for parent-child relationship concerns
The parent-child relationship is the foundation for formative life experiences and is a common diagnosable concern in the professional counseling and human service field. This work briefly addresses the DSM-IV-TR diagnosis V 61.20 Parent Child Relational Problem, providing prevalence rates, and related risks as well as two specific intervention strategics. Intervention strategies include the use of temperament traits and the communication of love between individuals. A handout follows the text of this work which may be used with clients
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Pituitary adenomas are associated with a variety of clinical manifestations resulting from excessive hormone secretion and tumor mass effects, and require a multidisciplinary management approach. This article discusses the treatment modalities for the management of patients with a prolactinoma, Cushing's disease and acromegaly, and summarizes the options for medical therapy in these patients
Strong Interaction Physics at the Luminosity Frontier with 22 GeV Electrons at Jefferson Lab
This document presents the initial scientific case for upgrading the
Continuous Electron Beam Accelerator Facility (CEBAF) at Jefferson Lab (JLab)
to 22 GeV. It is the result of a community effort, incorporating insights from
a series of workshops conducted between March 2022 and April 2023. With a track
record of over 25 years in delivering the world's most intense and precise
multi-GeV electron beams, CEBAF's potential for a higher energy upgrade
presents a unique opportunity for an innovative nuclear physics program, which
seamlessly integrates a rich historical background with a promising future. The
proposed physics program encompass a diverse range of investigations centered
around the nonperturbative dynamics inherent in hadron structure and the
exploration of strongly interacting systems. It builds upon the exceptional
capabilities of CEBAF in high-luminosity operations, the availability of
existing or planned Hall equipment, and recent advancements in accelerator
technology. The proposed program cover various scientific topics, including
Hadron Spectroscopy, Partonic Structure and Spin, Hadronization and Transverse
Momentum, Spatial Structure, Mechanical Properties, Form Factors and Emergent
Hadron Mass, Hadron-Quark Transition, and Nuclear Dynamics at Extreme
Conditions, as well as QCD Confinement and Fundamental Symmetries. Each topic
highlights the key measurements achievable at a 22 GeV CEBAF accelerator.
Furthermore, this document outlines the significant physics outcomes and unique
aspects of these programs that distinguish them from other existing or planned
facilities. In summary, this document provides an exciting rationale for the
energy upgrade of CEBAF to 22 GeV, outlining the transformative scientific
potential that lies within reach, and the remarkable opportunities it offers
for advancing our understanding of hadron physics and related fundamental
phenomena.Comment: Updates to the list of authors; Preprint number changed from theory
to experiment; Updates to sections 4 and 6, including additional figure
Troponin Is Unrelated to Outcomes in Heart Failure Patients Discharged From the Emergency Department
Background: Prior data has demonstrated increased mortality in hospitalized patients with acute heart failure (AHF) and troponin elevation. No data has specifically examined the prognostic significance of troponin elevation in patients with AHF discharged after emergency department (ED) management.
Objective: Evaluate the relationship between troponin elevation and outcomes in patients with AHF who are treated and released from the ED.
Methods: This was a secondary analysis of the Get with the Guidelines to Reduce Disparities in AHF Patients Discharged from the ED (GUIDED-HF) trial, a randomized, controlled trial of ED patients with AHF who were discharged. Patients with elevated conventional troponin not due to acute coronary syndrome (ACS) were included. Our primary outcome was a composite endpoint: time to 30-day cardiovascular death and/or heart failure-related events.
Results: Of the 491 subjects included in the GUIDED-HF trial, 418 had troponin measured during the ED evaluation and 66 (16%) had troponin values above the 99th percentile. Median age was 63 years (interquartile range, 54-70), 62% (n = 261) were male, 63% (n = 265) were Black, and 16% (n = 67) experienced our primary outcome. There were no differences in our primary outcome between those with and without troponin elevation (12/66, 18.1% vs 55/352, 15.6%; P = 0.60). This effect was maintained regardless of assignment to usual care or the intervention arm. In multivariable regression analysis, there was no association between our primary outcome and elevated troponin (hazard ratio, 1.00; 95% confidence interval, 0.49-2.01, P = 0.994).
Conclusion: If confirmed in a larger cohort, these findings may facilitate safe ED discharge for a group of patients with AHF without ACS when an elevated troponin is the primary reason for admission